# Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State

> **NCT00693121** · PHASE4 · COMPLETED · sponsor: **Methodist Rehabilitation Center** · enrollment: 79 (actual)

## Conditions studied

- Traumatic Brain Injury
- Posttraumatic Confusional State
- Delirium

## Interventions

- **DRUG:** Amantadine hydrochloride
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT00693121
- **Lead sponsor:** Methodist Rehabilitation Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2007-11
- **Final completion:** 2019-03
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2023-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693121, "Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00693121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*